Tamar Bridge News is your trusted guide through the currents of UK news, committed to bridging the gap between information and insight with clarity, precision, and a human-centric approach.
Kyowa Kirin International (KKI) has announced the upcoming presentation of interim findings from three significant real-world studies focusing on cutaneous T-cell lymphoma (CTCL) at the European Organisation for Research and Treatment of Cancer’s Cutaneous Lymphoma Tumour Group (EORTC-CLTG) annual meeting. The event is set to take place in Lausanne, Switzerland, from 9 to 11 October 2024. These studies involve participants from Europe, the United States, and the United Arab Emirates, and aim to gather evidence regarding the effectiveness of mogamulizumab, a pioneering humanised monoclonal antibody therapy. This treatment is currently approved in Europe and the UAE for adult patients with…